Insect Cell-Expressed Major Ragweed Allergen Amb a 1.01 Exhibits Similar Allergenic Properties to Its Natural Counterpart from Common Ragweed Pollen

Maria-Roxana Buzan,Manuela Grijincu,Lauriana-Eunice Zbîrcea,Laura Haidar,Tudor-Paul Tamaș,Monica-Daniela Cotarcă,Gabriela Tănasie,Milena Weber,Elijahu Babaev,Frank Stolz,Rudolf Valenta,Virgil Păunescu,Carmen Panaitescu,Kuan-Wei Chen
DOI: https://doi.org/10.3390/ijms25105175
IF: 5.6
2024-05-10
International Journal of Molecular Sciences
Abstract:Common ragweed pollen allergy has become a health burden worldwide. One of the major allergens in ragweed allergy is Amb a 1, which is responsible for over 90% of the IgE response in ragweed-allergic patients. The major allergen isoform Amb a 1.01 is the most allergenic isoform in ragweed pollen. So far, no recombinant Amb a 1.01 with similar allergenic properties to its natural counterpart (nAmb a 1.01) has been produced. Hence, this study aimed to produce a recombinant Amb a 1.01 with similar properties to the natural isoform for improved ragweed allergy management. Amb a 1.01 was expressed in insect cells using a codon-optimized DNA construct with a removable N-terminal His-Tag (rAmb a 1.01). The recombinant protein was purified by affinity chromatography and physicochemically characterized. The rAmb a 1.01 was compared to nAmb a 1.01 in terms of the IgE binding (enzyme-linked immunosorbent assay (ELISA), immunoblot) and allergenic activity (mediator release assay) in well-characterized ragweed-allergic patients. The rAmb a 1.01 exhibited similar IgE reactivity to nAmb a 1.01 in different IgE-binding assays (i.e., IgE immunoblot, ELISA, quantitative ImmunoCAP inhibition measurements). Furthermore, the rAmb a 1.01 showed comparable dose-dependent allergenic activity to nAmb a 1.01 regarding basophil activation. Overall, the results showed the successful expression of an rAmb a 1.01 with comparable characteristics to the corresponding natural isoform. Our findings provide the basis for an improvement in ragweed allergy research, diagnosis, and immunotherapy.
biochemistry & molecular biology,chemistry, multidisciplinary
What problem does this paper attempt to address?
The problem this paper attempts to address is the development of a recombinant major ragweed allergen Amb a 1.01 (rAmb a 1.01) with similar allergenic properties to its natural counterpart (nAmb a 1.01). Ragweed pollen allergy has become a global health burden, with Amb a 1 being the major allergen responsible for over 90% of IgE responses in ragweed allergy patients. Amb a 1.01 is the most allergenic isoform in ragweed pollen. However, to date, no recombinant Amb a 1.01 with similar allergenic properties to the natural isoform has been produced. Therefore, this study aims to produce a recombinant Amb a 1.01 through an insect cell expression system, with physicochemical properties, IgE binding capacity, and allergenic activity similar to the natural isoform, to improve the management, diagnosis, and immunotherapy of ragweed allergy. The success of this study will provide a basis for molecular diagnosis and specific immunotherapy of ragweed allergy.